Pazopanib is a multi-targeted receptor tyrosine kinase inhibitor indicated for the treatment of advanced renal cell carcinoma and advanced soft tissue sarcomas. This category contains a comprehensive range… Read more


















![Chemical structure of 5-((4-((1,2-Dihydroazeto[1,2-b]indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1821666-72-1-5-4-12-Dihydroazeto12-bindazol-6-ylmethylaminopyrimidin-2-ylamino-2-methylbenzenesulfonamide.png&w=3840&q=75)






























Pazopanib is a multi-targeted receptor tyrosine kinase inhibitor indicated for the treatment of advanced renal cell carcinoma and advanced soft tissue sarcomas. This category contains a comprehensive range of reference standards, including impurities, metabolites, and stable isotope labelled compounds, which are essential for rigorous analytical testing and quality control in pharmaceutical laboratories. These materials are used to facilitate precise impurity profiling, enabling the identification and quantification of process-related compounds, degradation products, and synthetic intermediates during drug development. Furthermore, stable isotope labelled Pazopanib compounds serve as vital internal standards in liquid chromatography-mass spectrometry (LC-MS) assays, providing the high level of accuracy required for bioanalytical method validation. By supporting detailed structural characterization and regulatory compliance, these reference materials assist researchers in maintaining the stringent analytical standards necessary for evaluating drug safety and efficacy throughout the product lifecycle.